Catamaran Corporation v. Towncrest Pharmacy

946 F.3d 1020
CourtCourt of Appeals for the Eighth Circuit
DecidedJanuary 10, 2020
Docket17-3501
StatusPublished
Cited by5 cases

This text of 946 F.3d 1020 (Catamaran Corporation v. Towncrest Pharmacy) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Catamaran Corporation v. Towncrest Pharmacy, 946 F.3d 1020 (8th Cir. 2020).

Opinion

United States Court of Appeals For the Eighth Circuit ___________________________

No. 17-3501 ___________________________

Catamaran Corporation

lllllllllllllllllllllPlaintiff - Appellee

v.

Towncrest Pharmacy; Clark’s Pharmacy; Meyer’s Healthmart Pharmacy; Osterhaus Pharmacy

lllllllllllllllllllllDefendants - Appellants ____________

Appeal from United States District Court for the Southern District of Iowa - Des Moines ____________

Submitted: October 15, 2019 Filed: January 10, 2020 ____________

Before LOKEN, SHEPHERD, and STRAS, Circuit Judges. ____________

SHEPHERD, Circuit Judge.

This case returns to us after remand to the district court to consider whether a contractual basis for class arbitration exists in the agreements between the parties. Catamaran Corp. v. Towncrest Pharmacy, 864 F.3d 966 (8th Cir. 2017) (Catamaran I). On remand, the district court1 granted Catamaran Corporation’s motion for summary judgment, finding there was no such contractual basis in the agreements. Towncrest Pharmacy, Clark’s Pharmacy, Meyer’s Healthmart Pharmacy, and Osterhaus Pharmacy (collectively, the pharmacies) appeal. Having jurisdiction under 28 U.S.C. § 1291, we now affirm.

I.

The facts of this case are extensively detailed in Catamaran I. As relevant to this appeal, Catamaran is a pharmacy benefit manager. It contracts with entities that sponsor, administer, or otherwise participate in prescription drug benefit plans. Among other services, Catamaran reimburses pharmacies that furnish prescription drugs to plan members. At issue are two agreements for such reimbursements between the pharmacies and Catamaran’s predecessors-in-interest, SXC Health Solutions Corp. and Catalyst Health Solutions, Inc. The pharmacies entered into these agreements through a pharmacy services administration organization, AccessHealth, of which the pharmacies are members. AccessHealth acted as attorney-in-fact for the pharmacies and signed the agreements on their behalf. Both agreements contain arbitration provisions. The SXC Agreement provides that after informal discussions fail, “either party may submit the dispute to binding arbitration in accordance with the Rules for the Conduct of Arbitration of the American Arbitration Association [AAA] . . . .” Similarly, the Catalyst Agreement provides “[a]ny controversy or claim arising out of or relating to this Agreement shall be settled by arbitration in accordance with the applicable rules of the [AAA].” As we noted in Catamaran I, “[n]either agreement uses the word ‘class’ or refers to class arbitration.” 864 F.3d at 969.

1 The Honorable Stephanie M. Rose, United States District Judge for the Southern District of Iowa.

-2- After a dispute between the parties arose, the pharmacies filed a demand for class arbitration with the AAA. Catamaran initiated an action in the district court seeking to prevent the pharmacies from pursuing class arbitration. Catamaran then moved for summary judgment and the district court denied the motion, finding that the agreements committed the class arbitration question to an arbitrator. On appeal, this Court reversed, holding that the question of whether the agreements provide for class arbitration is a substantive question of arbitrability, and thus presumptively a question for the court to decide, and the agreements did not otherwise commit the question to an arbitrator. We remanded the case to the district court to determine “whether such a ‘contractual basis’ for class arbitration exists in the agreements between Catamaran and the pharmacies.” Id. at 973-74. On remand, the district court found that there was no such contractual basis. The district court thus granted Catamaran’s motion for summary judgment and entered the requested declaratory judgment prohibiting class arbitration. The pharmacies now appeal.

II.

The pharmacies argue the district court erred because the agreements establish a contractual basis for class arbitration. We review de novo a district court’s order granting summary judgment. Lamoureux v. MPSC, Inc., 849 F.3d 737, 739 (8th Cir. 2017). Under the Federal Arbitration Act (FAA), 9 U.S.C. § 1 et. seq., a party may “petition a United States district court for an order directing that arbitration proceed in the manner provided for in such agreement” because the “primary purpose of the FAA is to ensure that private agreements to arbitrate are enforced according to their terms.” Stolt-Nielsen S.A. v. AnimalFeeds Int’l Corp., 559 U.S. 662, 682 (2010) (internal quotation marks omitted). “In this endeavor, as with any other contract, the parties’ intentions control.” Id. (internal quotation marks omitted). As such, the Supreme Court in Stolt-Nielsen held that “a party may not be compelled under the FAA to submit to class arbitration unless there is a contractual basis for concluding that the party agreed to do so.” Id. at 684. Further, the Supreme Court recently

-3- reaffirmed and clarified the contractual basis standard in Lamps Plus, Inc. v. Varela in which the Court held that an ambiguous agreement cannot provide the necessary contractual basis to conclude that the parties agreed to class arbitration. 139 S. Ct. 1407, 1416-17 (2019) (“Neither silence nor ambiguity provides a sufficient basis for concluding that parties to an arbitration agreement agreed to undermine the central benefits of arbitration itself.”). Accordingly, we must determine whether there is an affirmative contractual basis to conclude that the parties agreed to class arbitration. See id.

As the pharmacies concede, the agreements do not explicitly authorize class arbitration or even reference it at all. Other circuits have determined that such “[s]ilence regarding class arbitration generally indicates a prohibition . . . .” Quilloin v. Tenet HealthSystem Phila., Inc., 673 F.3d 221, 232 (3d Cir. 2012); see also Opalinski v. Robert Half Int’l Inc., 677 F. App’x 738, 741 (3d Cir. 2017) (collecting cases). Indeed, this Court has affirmed a denial of a request to arbitrate as a class, based on arbitration clauses in partnership agreements, because “the goal of the FAA is to enforce the agreement of the parties” and “the partnership agreements ma[de] no provision for arbitration as a class.” Dominium Austin Partners, L.L.C. v. Emerson, 248 F.3d 720, 728 (8th Cir. 2001). The rationale behind this interpretation of silence is that there are fundamental differences between individual and class arbitration, including that in a class arbitration proceeding: (1) the benefits of arbitration are “substantially lessened”; (2) the presumption of confidentiality and privacy “is lost or becomes more difficult”; (3) the commercial stakes are much higher with limited judicial review; and (4) due process concerns arise because it adjudicates the rights of absent parties. Catamaran I, 864 F.3d at 971-72 (citing Stolt-Nielsen, 559 U.S. at 685-87). These fundamental differences dictate against “presum[ing] . . . that the parties’ mere silence on the issue of class-action arbitration constitutes consent to resolve their disputes in class proceedings.” Stolt-Nielsen, 559 U.S. at 687.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
946 F.3d 1020, Counsel Stack Legal Research, https://law.counselstack.com/opinion/catamaran-corporation-v-towncrest-pharmacy-ca8-2020.